ASX:RHT Resonance Health (RHT) Stock Price, News & Analysis → This Could be Your “Big Money” AI Moment (From InvestorPlace) (Ad) Free RHT Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2.57 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield5.77%Price TargetN/A Stock AnalysisStock Analysis Get Resonance Health alerts: Email Address Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. About Resonance Health Stock (ASX:RHT)Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in the Asia Pacific, North America, Europe, the Middle East, and Africa. The company offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device for the automated real-time assessment of LIC; HepaFat-AI, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading; HepaFat-Scan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; and LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFat-AI into a consolidated report. It also provides quantitative imaging measurements and CRO services, such as quality-assured image analysis, project and data management, and issue resolution services; biomarkers, genomics, and laboratory analysis services, as well as works with third party pathology laboratories for blood/sample collection and for standard biochemical/lab safety assessments; design and protocol development, and project management and monitoring services; assessment of subject inclusion or exclusion, evaluating the safety profile of a new therapy, and supporting primary and secondary end-points demonstrating drug efficacy services; and phantoms for the MRI machines. The company serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.Read More Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. RHT Stock News HeadlinesMay 20 at 6:46 PM | msn.comAfrican anti-rights groups and anti-vaxxers unite in global conspiracy against WHOMay 20 at 1:46 PM | msn.comMumbai's Business Titans Cast Votes in Lok Sabha ElectionsMay 19 at 12:55 PM | msn.comAdvocates hope Alberta will follow new guidelines, lower breast cancer screening age to 40May 19 at 7:54 AM | yahoo.comMonroe man receives gold medal for excellence in nuclear medical physicsMay 18 at 3:49 PM | msn.comPrecancerous or Cancerous Biopsy for Polyps: What Happens Next?May 17, 2024 | newsweek.comWhy the Parents' Rights Movement (Still) Matters | OpinionMay 17, 2024 | msn.comNew blood test for strokes could help tackle a $2 trillion problem, researchers sayMay 17, 2024 | msn.comSelf-Care for New Moms & Kids Under 5' spotlights motherhood, featuring a theme song by folk singer Geeta RabariMay 16, 2024 | msn.comBlood test could detect preeclampsia in first trimester, LabCorp reportsMay 16, 2024 | msn.comAlyssa Fox Defies Gravity, and History, as Broadway’s First Asian ElphabaMay 15, 2024 | msn.comThese Coworkers-Turned-Friends Started a Side Hustle on Amazon — Now It's a 'Full Hustle' Earning Over $20 Million a Year: 'Jump in With Both Feet'May 15, 2024 | msn.comReport shows disparities in cancer outcomes based on race, location, sexualityMay 15, 2024 | msn.comTwins’ center fielder Byron Buxton ready for rehab outingMay 14, 2024 | msn.comTwins’ center fielder Byron Buxton nears rehab outingMay 14, 2024 | msn.com'A pretty amazing piece of equipment': Portable pediatric MRI now available at Sask. children's hospitalMay 14, 2024 | nytimes.comAlice Munro, Nobel Laureate and Master of the Short Story, Dies at 92May 14, 2024 | msn.comIt Took Me Years to Find the Right Psoriatic Arthritis MedicationMay 12, 2024 | nytimes.comFast Food Forever: How McHaters Lost the Culture WarMay 12, 2024 | theguardian.comUrgent memo to Sir Keir Starmer: there are some offers which should be refusedMay 10, 2024 | msn.comWatch: Bride's Tearful Reaction to Unexpected Wedding Day GiftMay 9, 2024 | msn.comQ&A: Do you know your risks for breast cancer?May 9, 2024 | msn.comHow ultrasound and microbubbles could deliver immunotherapy to the brainMay 8, 2024 | msn.comLily James' $3k Met Gala facial with energy cleansing and mantraMay 7, 2024 | forbes.comThe $3,000 Facial That Prepped Actress Lily James For The Met GalaMay 7, 2024 | msn.comEverything you need to know about fretwraps: what are they and do you need one?See More Headlines Receive RHT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Resonance Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:RHT CUSIPN/A CIKN/A Webwww.resonancehealth.com Phone61 8 9286 5300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,090,000.00 Net Margins-19.27% Pretax MarginN/A Return on Equity-10.73% Return on Assets-6.56% Debt Debt-to-Equity Ratio3.26 Current Ratio8.25 Quick Ratio9.76 Sales & Book Value Annual Sales$5.64 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow22.50 Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares446,890,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.33 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Mitchell M. Wells B.Com. (Age 49)B.Comm, L.L.B., LLB, Company Secretary & Non Executive Director Comp: $274.56kMr. Andrew Duncan Harrison BCom (Hons) (Age 53)MAICD, Chief Executive Officer Mr. Benjamin CarruthersChief Financial OfficerMs. Liesl ElliesGeneral CounselMr. Chad TondutCommunications Manager and GM of Products & PortfolioMr. Ajay NairGeneral Manager of Global Sales & MarketingDr. Timothy Guy St. Pierre B.Sc(Hons)Ph.D., Chief Research ScientistDr. Wenjie Pang Ph.D.Chief Scientific Officer Imaging & AIDr. Sherif Boulos Ph.D.Chief Scientific Officer of MolecularMore ExecutivesKey Competitors1st GroupASX:1STAclarionNASDAQ:ACONWAlcidion GroupASX:ALCArcturis DataOTCMKTS:SSYNFArtryaASX:AYAView All CompetitorsInsidersSimon PantonBought 500,000 shares on 4/8/2024Total: $32,500.00 ($0.07/share)Mitchell WellsSold 610,000 sharesTotal: $36,600.00 ($0.06/share)Travis BaroniBought 610,000 shares on 9/27/2023Total: $44,530.00 ($0.07/share)Aaron BrinkworthBought 300,000 shares on 9/5/2023Total: $19,800.00 ($0.07/share) RHT Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Resonance Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Resonance Health investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Arbor Realty Trust (ABR), Advanced Emissions Solutions (ADES), Archer-Daniels-Midland (ADM), AGNC Investment (AGNC) and AMC Entertainment (AMC). This page (ASX:RHT) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Resonance Health Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.